CD
Cocaine
search
Cocaine
, Cocaine Abuse, Cocaine Intoxication, Cocaine Toxicity
See Also
Cocaine-Induced Coronary Vasospasm
Stimulant Use Disorder
Amphetamine
MDMA
Methamphetamine
Chemical Dependency
Substance Abuse Evaluation
Intravenous Drug Abuse
Background
Naturally derived from Coca plant
South American shrub
Not the same as the cocoa plant
Class
Stimulant
Local Anesthetic
Schedule I
Preparations
Formulations (same Cocaine molecule and CNS, cardiovascular effects despite different delivery methods)
Salt: Fine white powder (blow, coke, snow)
Snorted or mixed with water and injected
Base: Crystalline or Rock Crystal (Crack Cocaine)
Appears similar to soap pieces caked together
Smoked (vaporizes when heated)
Second-hand inhalation can effect infants and children
Street Names
Coke
Snow Flake
Toot
Star Dust
Happy Dust
Bernice
Methods of abuse
Swallowed
Snorted
Intravenous
Freebase residue
Smoked (solid crack)
Mechanism
Affects central and peripheral
Neurotransmitter
s (blocks their reuptake)
Norepinephrine
Dopamine
- arousal
Serotonin
- awakening
Class Ib Antiarrhythmic Drug
Sodium Channel Blocker
that shortens
Action Potential
duration
Pharmacokinetics
Metabolized by serum and hepatic
Choline
sterases
Excreted by
Kidney
s
Crosses the placenta by simple diffusion
Crosses into
Breast Milk
Prolonged Duration and toxicity
Excessive intake
"
Body Packer
s" with ruptured bag
Concurrent
Alcohol
ingestion
Cocaine (20-300 mg)
Onset intranasal effects in 1 hour
Onset faster with intravenous or smoked forms
Duration: 2-4 hours
Half life: 90 minutes
Peak Toxicity
Swallowing
: 60-90 minutes
Snorting: 30-60 minutes
Intravenous or Smoked: Minutes
Symptoms
Increased energy and alertness
Euphoria
Sociability
Appetite suppression
Decreased need for sleep
Restlessness
Excitement
Signs
Toxicity (Systemic
Sympathomimetic
Effect)
See
Cocaine-Induced Coronary Vasospasm
See
Sympathomimetic Toxicity
Hypertensive
Sinus Tachycardia
(significant)
Tremor
s
Agitation
Generalized Tonic Clonic Seizure
s
Pressured speech
Diaphoresis
Contrast with
Amitriptyline
Overdose
which causes dryness (instead of diaphoresis)
Diagnostics
Electrocardiogram
QRS Widening
Sinus Tachycardia
Paroxysmal Supraventricular Tachycardia
and other tachyarrhythmias
Adverse Effects (increased with duration and dose)
Acute effects
See
Cocaine-Induced Coronary Vasospasm
See
Sympathomimetic Toxicity
Psychosis
(e.g.
Hallucination
s, paranoia) in 80% of patients
Aortic Dissection
Cerebrovascular Accident
(both ischemic and
Hemorrhagic CVA
)
Hypertension
Crack
Lung
(diffuse alveolar injury)
Tactile Hallucination
s (crawling bugs)
Chronic effects
Cardiomyopathy
Perforated nasal septum
Memory Loss
Movement Disorder
s
Psychiatric disorders
Labs
See
Urine Drug Screen
Detectable in blood, urine, hair,
Saliva
, sweat,
Breast Milk
Management
Toxicity
See
Sympathomimetic Toxicity
See
Cocaine-Induced Coronary Vasospasm
Avoid
Beta Blocker
s (risk of unopposed alpha-
Agonist
effect)
Administer
Benzodiazepine
s
Preferred agents in
Seizure
s
Preferred agents in
Sympathomimetic Toxicity
(
Agitation
,
Hypertension
,
Tachycardia
)
Treat hyperthermia with cooling
Evaluate for
Dysrhythmia
Treat
Seizure
s (starting with
Benzodiazepine
s)
See
Status Epilepticus
Management
Withdrawal
Ativan
until adequate sedation
May require significant dosages
Propranolol
20 mg qid (indicated for chills)
Beta Blocker
s are typically avoided in Cocaine use - theoretical risk of coronary vasospasm
Management
Abstinence
Combined group and individual counseling most effective
Minozzi (2016) Cochrane Database Syst Rev (9):CD011866 [PubMed]
Study of effective options for therapy
Cognitive behavior therapy
Disulfiram
(effective even if no
Alcohol Abuse
)
Caroll (2004) Arch Gen Psychiatry 61:264-72 [PubMed]
Medication therapy
No medications have been found significantly helpful
Disulfiram
use supported by only low level evidence
Substitution Therapy (e.g.
Ritalin
replaces Cocaine) may have benefit (experimental)
Castelis (2016) (9):CD007380 [PubMed]
References
Moore, Behar, Claudius and Farrah in Herbert (2018) EM:Rap 18(5):11-2
Tagliaferro (2023) Crit Dec Emerg Med 37(1): 21-9
Klega (2018) Am Fam Physician 98(2): 85-92 [PubMed]
Shih (1996) Hosp Physician p. 11-20 [PubMed]
Type your search phrase here